Skip to content

CryoPort, Inc. CYRX Notes Payable

Notes Payable at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$400.5M+33,275%

Other financials

Income statement

See full
Revenue$47.8M+16.5%
Gross profit$21.9M+17.6%
Operating income-$9.6M-33.6%
Net income-$10.5M+12.0%
EPS (diluted)-$0.25+10.7%

Balance sheet

See full
Cash & equivalents$272.9M+656%
Total debt$230.7M+293%
Total equity$495.0M+24.1%
Total assets$763.6M+9.1%

Cash flow

See full
Operating cash flow$3.7M+186%
CapEx$10.0M+215%
Free cash flow-$6.2M+16.8%

Valuation

See full
Market cap$800.39M+151%
Enterprise value$758.23M+122%
P/E10.6×
P/S4.4×+2.4×

Profitability

See full
Gross margin47.2%+1.6pp
Operating margin-21.4%-8.8pp
Net margin39.2%+22.1pp
FCF margin-13%-3.6pp

Returns & leverage

See full
Return on equity14.5%+8.6pp
Debt / equity0.5×+0.3×
Current ratio2.1×-3.5×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NotesPayableCurrent.

The official record: CryoPort, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CryoPort, Inc.'s notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CryoPort, Inc.'s notes payable?
CryoPort, Inc. (CYRX) reported notes payable of $159K in Q1 2026.
How has CryoPort, Inc.'s notes payable changed year-over-year?
CryoPort, Inc.'s notes payable increased by 6.7% year-over-year, from $149K to $159K.
What is the long-term trend for CryoPort, Inc.'s notes payable?
Over 3 years (2022 to 2025), CryoPort, Inc.'s notes payable has grown at a 39.5% compound annual growth rate (CAGR), from $60K to $163K.
What does notes payable mean?
This represents the principal amount of debt obligations evidenced by formal promissory notes due within the standard operating cycle or one year. It serves as a measure of short-term financing requirements and liquidity pressure on the company's cash flow. Monitoring this metric helps investors assess the company's reliance on near-term credit facilities to fund ongoing operations.